Works matching AU Linn, Sabine C.

Results: 70
    1
    2
    3

    Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics.

    Published in:
    International Journal of Technology Assessment in Health Care, 2009, v. 25, n. 1, p. 73, doi. 10.1017/S0266462309090102
    By:
    • Valesca P. Ret?l;
    • Jolien M. Bueno-de-Mesquita;
    • Marjan J. M. Hummel;
    • Marc J. van de Vijver;
    • Kirsten F. L. Douma;
    • Kim Karsenberg;
    • Frits S. A. M. van Dam;
    • Cees van Krimpen;
    • Frank E. Bellot;
    • Rudi M. H. Roumen;
    • Sabine C. Linn;
    • Wim H. van Harten
    Publication type:
    Article
    4
    5

    4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

    Published in:
    Molecular Oncology, 2016, v. 10, n. 1, p. 24, doi. 10.1016/j.molonc.2015.07.004
    By:
    • De Marchi, Tommaso;
    • Liu, Ning Qing;
    • Stingl, Cristoph;
    • Timmermans, Mieke A.;
    • Smid, Marcel;
    • Look, Maxime P.;
    • Tjoa, Mila;
    • Braakman, Rene B.H.;
    • Opdam, Mark;
    • Linn, Sabine C.;
    • Sweep, Fred C.G.J.;
    • Span, Paul N.;
    • Kliffen, Mike;
    • Luider, Theo M.;
    • Foekens, John A.;
    • Martens, John W.M.;
    • Umar, Arzu
    Publication type:
    Article
    6

    Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
    By:
    • Jansen, Maurice P.H.M.;
    • Sas, Leen;
    • Sieuwerts, Anieta M.;
    • Van Cauwenberghe, Caroline;
    • Ramirez-Ardila, Diana;
    • Look, Maxime;
    • Ruigrok-Ritstier, Kirsten;
    • Finetti, Pascal;
    • Bertucci, François;
    • Timmermans, Mieke M.;
    • van Deurzen, Carolien H.M.;
    • Martens, John W.M.;
    • Simon, Iris;
    • Roepman, Paul;
    • Linn, Sabine C.;
    • van Dam, Peter;
    • Kok, Marleen;
    • Lardon, Filip;
    • Vermeulen, Peter B.;
    • Foekens, John A.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.

    Published in:
    JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad092
    By:
    • Lammers, Senna W M;
    • Geurts, Sandra M E;
    • Hellemond, Irene E G van;
    • Swinkels, Astrid C P;
    • Smorenburg, Carolien H;
    • Sangen, Maurice J C van der;
    • Kroep, Judith R;
    • Graaf, Hiltje de;
    • Honkoop, Aafke H;
    • Erdkamp, Frans L G;
    • Roos, Wilfred K de;
    • Linn, Sabine C;
    • Imholz, Alexander L T;
    • Smidt, Marjolein L;
    • Vriens, Ingeborg J H;
    • Tjan-Heijnen, Vivianne C G
    Publication type:
    Article
    13
    14
    15

    Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 16, p. 2746, doi. 10.1002/cncr.35323
    By:
    • Schettini, Francesco;
    • Blondeaux, Eva;
    • Molinelli, Chiara;
    • Bas, Raphaëlle;
    • Kim, Hee Jeong;
    • Di Meglio, Antonio;
    • Bernstein Molho, Rinat;
    • Linn, Sabine C.;
    • Pogoda, Katarzyna;
    • Carrasco, Estela;
    • Punie, Kevin;
    • Agostinetto, Elisa;
    • Lopetegui‐Lia, Nerea;
    • Phillips, Kelly‐Anne;
    • Toss, Angela;
    • Rousset‐Jablonski, Christine;
    • Acheritogaray, Marion;
    • Ferrari, Alberta;
    • Paluch‐Shimon, Shani;
    • Fruscio, Robert
    Publication type:
    Article
    16
    17

    IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women.

    Published in:
    NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00344-3
    By:
    • Joosten, Stacey E. P.;
    • Wellenstein, Marius;
    • Koornstra, Rutger;
    • van Rossum, Annelot;
    • Sanders, Joyce;
    • van der Noort, Vincent;
    • Ferrandez, Maria C.;
    • Harkes, Rolf;
    • Mandjes, Ingrid A. M.;
    • Rosing, Hilde;
    • Huitema, Alwin;
    • Beijnen, Jos H.;
    • Wesseling, Jelle;
    • van Diest, Paul J.;
    • Horlings, Hugo M.;
    • Linn, Sabine C.;
    • Zwart, Wilbert
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.

    Published in:
    International Journal of Cancer, 2019, v. 145, n. 5, p. 1325, doi. 10.1002/ijc.32205
    By:
    • Hellemond, Irene E.G.;
    • Smorenburg, Carolien H.;
    • Peer, Petronella G.M.;
    • Swinkels, Astrid C.P.;
    • Seynaeve, Caroline M.;
    • Sangen, Maurice J.C.;
    • Kroep, Judith R.;
    • de Graaf, Hiltje;
    • Honkoop, Aafke H.;
    • Erdkamp, Frans L.G.;
    • Berkmortel, Franchette W.P.J.;
    • Boer, Maaike;
    • Roos, Wilfred K.;
    • Linn, Sabine C.;
    • Imholz, Alexander L.T.;
    • Tjan‐Heijnen, Vivianne C.G.
    Publication type:
    Article
    26

    Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure.

    Published in:
    International Journal of Cancer, 2019, v. 145, n. 1, p. 274, doi. 10.1002/ijc.32093
    By:
    • Hellemond, Irene E.G.;
    • Vriens, Ingeborg J.H.;
    • Peer, Petronella G.M.;
    • Swinkels, Astrid C.P.;
    • Smorenburg, Carolien H.;
    • Seynaeve, Caroline M.;
    • Sangen, Maurice J.C.;
    • Kroep, Judith R.;
    • Graaf, Hiltje;
    • Honkoop, Aafke H.;
    • Erdkamp, Frans L.G.;
    • Berkmortel, Franchette W.P.J.;
    • Boer, Maaike;
    • Roos, Wilfred K.;
    • Linn, Sabine C.;
    • Imholz, Alexander L.T.;
    • Tjan‐Heijnen, Vivianne C.G.
    Publication type:
    Article
    27

    BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 4, p. 882, doi. 10.1002/ijc.30078
    By:
    • Schouten, Philip C.;
    • Gluz, Oleg;
    • Harbeck, Nadia;
    • Mohrmann, Svjetlana;
    • Diallo‐Danebrock, Raihana;
    • Pelz, Enrico;
    • Kruizinga, Janneke;
    • Velds, Arno;
    • Nieuwland, Marja;
    • Kerkhoven, Ron M.;
    • Liedtke, Cornelia;
    • Frick, Markus;
    • Kates, Ronald;
    • Linn, Sabine C.;
    • Nitz, Ulrike;
    • Marme, Frederik
    Publication type:
    Article
    28
    29

    Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA.

    Published in:
    Genome Medicine, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13073-018-0611-9
    By:
    • Gao, Meiling;
    • Callari, Maurizio;
    • Sammut, Stephen-John;
    • Grzelak, Marta;
    • Chin, Suet-Feung;
    • Beddowes, Emma;
    • Caldas, Carlos;
    • Biggs, Heather;
    • Jones, Linda;
    • Boumertit, Abdelhamid;
    • Baird, Richard;
    • Linn, Sabine C.;
    • Cortes, Javier;
    • Oliveira, Mafalda
    Publication type:
    Article
    30
    31

    A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.

    Published in:
    2016
    By:
    • Drooger, Jan C.;
    • van Tinteren, Harm;
    • de Groot, Steffen M.;
    • ten Tije, Albert J.;
    • de Graaf, Hiltje;
    • Portielje, Johanneke E. A.;
    • Jager, Agnes;
    • Honkoop, Aafke;
    • Linn, Sabine C.;
    • Kroep, Judith R.;
    • Erdkamp, Frans L. G.;
    • Hamberg, Paul;
    • Imholz, Alex L. T.;
    • van Rossum‐Schornagel, Quirine C.;
    • Heijns, Joan B.;
    • van Leeuwen‐Stok, A. Elise;
    • Sleijfer, Stefan
    Publication type:
    journal article
    32
    33
    34

    Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 2, p. e2461639, doi. 10.1001/jamanetworkopen.2024.61639
    By:
    • Richters, Lisa;
    • Gluz, Oleg;
    • Weber-Lassalle, Nana;
    • Christgen, Matthias;
    • Haverkamp, Heinz;
    • Kuemmel, Sherko;
    • Kayali, Mohamad;
    • Kates, Ronald E.;
    • Grischke, Eva-Maria;
    • Altmüller, Janine;
    • Forstbauer, Helmut;
    • Thiele, Holger;
    • Braun, Michael;
    • Warm, Mathias;
    • Ossowski, Anna;
    • Wuerstlein, Rachel;
    • Ernst, Corinna;
    • Graeser, Monika;
    • Linn, Sabine C.;
    • Nitz, Ulrike
    Publication type:
    Article
    35

    Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
    By:
    • Schouten, Philip C.;
    • Schmidt, Sandra;
    • Becker, Kerstin;
    • Thiele, Holger;
    • Nürnberg, Peter;
    • Richters, Lisa;
    • Ernst, Corinna;
    • Treilleux, Isabelle;
    • Medioni, Jacques;
    • Heitz, Florian;
    • Pisano, Carmela;
    • Garcia, Yolanda;
    • Petru, Edgar;
    • Hietanen, Sakari;
    • Colombo, Nicoletta;
    • Vergote, Ignace;
    • Nagao, Shoji;
    • Linn, Sabine C.;
    • Pujade-Lauraine, Eric;
    • Ray-Coquard, Isabelle
    Publication type:
    Article
    36
    37

    Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-02856-2
    By:
    • Severson, Tesa M.;
    • Yongsoo Kim;
    • Joosten, Stacey E. P.;
    • Schuurman, Karianne;
    • der Groep, Petra van;
    • Moelans, Cathy B.;
    • ter Hoeve, Natalie D.;
    • Manson, Quirine F.;
    • Martens, John W.;
    • van Deurzen, Carolien H. M.;
    • Barbe, Ellis;
    • Hedenfalk, Ingrid;
    • Bult, Peter;
    • Smit, Vincent T. H. B. M.;
    • Linn, Sabine C.;
    • van Diest, Paul J.;
    • Wessels, Lodewyk;
    • Zwart, Wilbert
    Publication type:
    Article
    38
    39
    40

    PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2 and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.

    Published in:
    Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3606
    By:
    • Beelen, Karin;
    • Opdam, Mark;
    • Severson, Tesa M.;
    • Koornstra, Rutger H. T.;
    • Vincent, Andrew D.;
    • Wesseling, Jelle;
    • Muris, Jettie J.;
    • Berns, Els M. J. J.;
    • Vermorken, Jan B.;
    • van Diest, Paul J.;
    • Linn, Sabine C.
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47

    Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.

    Published in:
    2022
    By:
    • Balkenende, Eva M E;
    • Dahhan, Taghride;
    • Beerendonk, Catharina C M;
    • Fleischer, Kathrin;
    • Stoop, Dominic;
    • Bos, Annelies M E;
    • Lambalk, Cornelis B;
    • Schats, Roel;
    • Smeenk, Jesper M J;
    • Louwé, Leonie A;
    • Cantineau, Astrid E P;
    • Bruin, Jan Peter de;
    • Linn, Sabine C;
    • van der Veen, Fulco;
    • Wely, Madelon van;
    • Goddijn, Mariëtte;
    • van Wely, Madelon;
    • de Bruin, Jan Peter
    Publication type:
    journal article
    48
    49
    50